BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 26835981)

  • 1. Self-reported Health Care Utilization of Patients with Inflammatory Bowel Disease Correlates Perfectly with Medical Records.
    Severs M; Petersen RE; Siersema PD; Mangen MJ; Oldenburg B
    Inflamm Bowel Dis; 2016 Mar; 22(3):688-93. PubMed ID: 26835981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study.
    Burisch J; Vardi H; Schwartz D; Friger M; Kiudelis G; Kupčinskas J; Fumery M; Gower-Rousseau C; Lakatos L; Lakatos PL; D'Incà R; Sartini A; Valpiani D; Giannotta M; Arebi N; Duricova D; Bortlik M; Chetcuti Zammit S; Ellul P; Pedersen N; Kjeldsen J; Midjord JMM; Nielsen KR; Winther Andersen K; Andersen V; Katsanos KH; Christodoulou DK; Domislovic V; Krznaric Z; Sebastian S; Oksanen P; Collin P; Barros L; Magro F; Salupere R; Kievit HAL; Goldis A; Kaimakliotis IP; Dahlerup JF; Eriksson C; Halfvarson J; Fernandez A; Hernandez V; Turcan S; Belousova E; Langholz E; Munkholm P; Odes S;
    Lancet Gastroenterol Hepatol; 2020 May; 5(5):454-464. PubMed ID: 32061322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Cost of Inflammatory Bowel Disease: An Initiative From the Crohn's & Colitis Foundation.
    Park KT; Ehrlich OG; Allen JI; Meadows P; Szigethy EM; Henrichsen K; Kim SC; Lawton RC; Murphy SM; Regueiro M; Rubin DT; Engel-Nitz NM; Heller CA
    Inflamm Bowel Dis; 2020 Jan; 26(1):1-10. PubMed ID: 31112238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory Bowel Diseases (Crohn´s Disease and Ulcerative Colitis): Cost of Treatment in Serbia and the Implications.
    Kostić M; Djakovic L; Šujić R; Godman B; Janković SM
    Appl Health Econ Health Policy; 2017 Feb; 15(1):85-93. PubMed ID: 27587010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic analysis of annual health resource utilization and costs in hospitalized patients with inflammatory bowel disease in Switzerland.
    Schoepfer A; Vavricka SR; Brüngger B; Reich O; Blozik E; Bähler C
    Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):868-875. PubMed ID: 29757772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults.
    Kappelman MD; Rifas-Shiman SL; Porter CQ; Ollendorf DA; Sandler RS; Galanko JA; Finkelstein JA
    Gastroenterology; 2008 Dec; 135(6):1907-13. PubMed ID: 18854185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic Burden and Health Care Access for Patients With Inflammatory Bowel Diseases in China: Web-Based Survey Study.
    Yu Q; Zhu C; Feng S; Xu L; Hu S; Chen H; Chen H; Yao S; Wang X; Chen Y
    J Med Internet Res; 2021 Jan; 23(1):e20629. PubMed ID: 33399540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mental Health Costs of Inflammatory Bowel Diseases.
    Szigethy E; Murphy SM; Ehrlich OG; Engel-Nitz NM; Heller CA; Henrichsen K; Lawton R; Meadows P; Allen JI
    Inflamm Bowel Dis; 2021 Jan; 27(1):40-48. PubMed ID: 32095835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smoking is Associated with Higher Disease-related Costs and Lower Health-related Quality of Life in Inflammatory Bowel Disease.
    Severs M; Mangen MJ; van der Valk ME; Fidder HH; Dijkstra G; van der Have M; van Bodegraven AA; de Jong DJ; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; van de Meeberg PC; Mahmmod N; Ponsioen CY; Vermeijden JR; van der Meulen-de Jong AE; Pierik M; Siersema PD; Oldenburg B;
    J Crohns Colitis; 2017 Mar; 11(3):342-352. PubMed ID: 27647859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct medical cost of managing IBD patients: a Canadian population-based study.
    Bernstein CN; Longobardi T; Finlayson G; Blanchard JF
    Inflamm Bowel Dis; 2012 Aug; 18(8):1498-508. PubMed ID: 22109958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study.
    van der Valk ME; Mangen MJ; Leenders M; Dijkstra G; van Bodegraven AA; Fidder HH; de Jong DJ; Pierik M; van der Woude CJ; Romberg-Camps MJ; Clemens CH; Jansen JM; Mahmmod N; van de Meeberg PC; van der Meulen-de Jong AE; Ponsioen CY; Bolwerk CJ; Vermeijden JR; Siersema PD; van Oijen MG; Oldenburg B;
    Gut; 2014 Jan; 63(1):72-9. PubMed ID: 23135759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Evolution of Health Care Utilisation and Costs for Inflammatory Bowel Disease Over Ten Years.
    Pillai N; Dusheiko M; Maillard MH; Rogler G; Brüngger B; Bähler C; Pittet VEH;
    J Crohns Colitis; 2019 May; 13(6):744-754. PubMed ID: 30916775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal Trends in the Direct Costs and Health Care Utilization Ascribable to Inflammatory Bowel Disease in the Biologic Era: Results From a Canadian Population-Based Analysis.
    Targownik LE; Kaplan GG; Witt J; Bernstein CN; Singh H; Tennakoon A; Aviña Zubieta A; Coward SB; Jones J; Kuenzig ME; Murthy SK; Nguyen GC; Peña-Sánchez JN; Benchimol EI
    Am J Gastroenterol; 2020 Jan; 115(1):128-137. PubMed ID: 31895723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct health care insurer and out-of-pocket expenditures of inflammatory bowel disease: evidence from a US national survey.
    Gunnarsson C; Chen J; Rizzo JA; Ladapo JA; Lofland JH
    Dig Dis Sci; 2012 Dec; 57(12):3080-91. PubMed ID: 22790905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital.
    Bernstein CN; Papineau N; Zajaczkowski J; Rawsthorne P; Okrusko G; Blanchard JF
    Am J Gastroenterol; 2000 Mar; 95(3):677-83. PubMed ID: 10710056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bowel disease: medical cost algorithms.
    Hay AR; Hay JW
    J Clin Gastroenterol; 1992 Jun; 14(4):318-27. PubMed ID: 1607608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health service utilization in IBD: comparison of self-report and administrative data.
    Longobardi T; Walker JR; Graff LA; Bernstein CN
    BMC Health Serv Res; 2011 May; 11():137. PubMed ID: 21627808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Out-of-pocket Cost Burden in Pediatric Inflammatory Bowel Disease: A Cross-sectional Cohort Analysis.
    Sin AT; Damman JL; Ziring DA; Gleghorn EE; Garcia-Careaga MG; Gugig RR; Hunter AK; Burgis JC; Bass DM; Park KT
    Inflamm Bowel Dis; 2015 Jun; 21(6):1368-77. PubMed ID: 25839776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cost measurement based on a cost diary in patients with inflammatory bowel disease].
    Rösch M; Leidl R; Tirpitz Cv; Reinshagen M; Adler G; König HH
    Z Gastroenterol; 2002 Apr; 40(4):217-28. PubMed ID: 11961730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.